Yunfeng Zhou Selected Research

Immunotherapy

1/2022	Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
10/2021	Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
1/2021	A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunfeng Zhou Research Topics

Disease

50	Neoplasms (Cancer) 12/2022 - 11/2006
11	Breast Neoplasms (Breast Cancer) 10/2023 - 03/2009
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2017
8	Fibrosis (Cirrhosis) 01/2023 - 03/2012
7	Inflammation (Inflammations) 01/2022 - 01/2008
7	Carcinogenesis 01/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2010
6	Triple Negative Breast Neoplasms 12/2022 - 05/2015
6	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2021 - 02/2015
5	Stomach Neoplasms (Stomach Cancer) 04/2019 - 01/2015
5	Prostatic Neoplasms (Prostate Cancer) 03/2019 - 08/2013
4	Pain (Aches) 01/2024 - 05/2014
4	Memory Disorders (Memory Loss) 08/2023 - 09/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2011
4	Nasopharyngeal Carcinoma 01/2022 - 10/2016
4	Infections 07/2021 - 01/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021 - 10/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2018 - 11/2015
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024 - 12/2007
3	Neuroinflammatory Diseases 12/2023 - 01/2021
3	Cognitive Dysfunction 12/2023 - 02/2023
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2020
3	Hypoxia (Hypoxemia) 10/2020 - 01/2019
3	Proteinuria 03/2018 - 06/2011
2	Body Weight (Weight, Body) 04/2024 - 12/2014
2	Knee Osteoarthritis 01/2024 - 01/2023
2	Brain Ischemia (Cerebral Ischemia) 12/2023 - 07/2019
2	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2019
2	Fatigue 12/2022 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2013
2	Melanoma (Melanoma, Malignant) 10/2021 - 05/2017
2	Hypertension (High Blood Pressure) 01/2021 - 03/2018
2	Osteosarcoma (Osteogenic Sarcoma) 12/2019 - 03/2014
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2019 - 01/2018
2	Wounds and Injuries (Trauma) 03/2018 - 06/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2017
2	Hyperglycemia 02/2017 - 05/2014
2	Non-alcoholic Fatty Liver Disease 01/2017 - 08/2013
2	Fatty Liver 01/2017 - 08/2013
2	Glioma (Gliomas) 11/2016 - 12/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2015 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 09/2009
2	Kidney Diseases (Kidney Disease) 01/2013 - 01/2012
2	Lewis Lung Carcinoma 09/2011 - 04/2011

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2011
13	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2024 - 09/2009
8	LuciferasesIBA 05/2016 - 07/2013
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2017
6	MicroRNAs (MicroRNA)IBA 10/2020 - 06/2014
5	EnzymesIBA 01/2022 - 09/2009
4	Telomere-Binding ProteinsIBA 01/2024 - 01/2013
4	CytokinesIBA 01/2023 - 12/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2024 - 11/2006
3	Therapeutic UsesIBA 10/2023 - 12/2007
3	Long Noncoding RNAIBA 09/2023 - 10/2018
3	apatinibIBA 07/2021 - 01/2021
3	Cyclin D1IBA 01/2021 - 01/2013
3	ZincIBA 01/2020 - 01/2009
3	Clioquinol (Vioform)FDA Link 01/2020 - 01/2009
3	Messenger RNA (mRNA)IBA 10/2018 - 01/2015
3	LigandsIBA 01/2012 - 01/2008
3	Horseradish PeroxidaseIBA 09/2011 - 09/2009
2	andrographolideIBA 12/2023 - 02/2023
2	InflammasomesIBA 12/2023 - 07/2023
2	Cytidine Triphosphate (CTP)IBA 12/2023 - 07/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2023 - 11/2021
2	CateninsIBA 10/2023 - 11/2016
2	Estrogen ReceptorsIBA 01/2023 - 12/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 12/2011
2	PhosphoglucomutaseIBA 05/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2008
2	Glucose OxidaseIBA 01/2022 - 01/2020
2	Angiogenesis InhibitorsIBA 01/2021 - 01/2021
2	CyclinsIBA 01/2021 - 12/2019
2	ribociclibIBA 12/2019 - 04/2019
2	AntigensIBA 03/2019 - 07/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2018 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 09/2008
2	Ubiquitin-Conjugating EnzymesIBA 05/2016 - 01/2016
2	Dual OxidasesIBA 01/2016 - 01/2016
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 02/2015 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 10/2013 - 03/2012
2	Triglycerides (Triacylglycerol)IBA 08/2013 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2012 - 09/2008
2	indoleIBA 09/2011 - 04/2011
2	Interleukin-12 (IL 12)IBA 09/2011 - 04/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2011 - 01/2008

Therapy/Procedure

19	Therapeutics 01/2024 - 11/2006
19	Radiotherapy 12/2022 - 09/2009
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
4	Chemoradiotherapy 06/2022 - 01/2019
3	Immunotherapy 01/2022 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 10/2020
2	Adjuvant Radiotherapy 02/2020 - 04/2019
2	Arthroscopes 07/2019 - 07/2019
2	Anterior Cruciate Ligament Reconstruction 12/2017 - 12/2017